Publication | Closed Access

In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s

Cannabis UseMolecular PharmacologyBiochemistryMedicineLiver PhysiologyVitro MetabolismHepatotoxicityNovel Synthetic CannabinoidHuman Liver MicrosomesMetabolismPharmacologyCannabinoid PharmacologyDrug-induced Liver InjuryHuman MetabolismDrug DiscoveryHealth Sciences